Clinical Pharmaceutical Aspects of Lithium Therapy

Cade J. F. : Lithium Salts in the Treatment of Psychotic Excitement, Med. J. Aust. 2: 349–352, 1949.

Schou M. : Lithium in Psychiatric Therapy and Prophylaxis, J. Psychiat. Res. 6: 67–95, 1968.

Schou M. : The Practical Management of Lithium Treatment, Brit. J. Hosp. Med. 6: 53–60, 1971.

Maggs R. : Treatment of Manic Illness with Lithium Carbonate, Brit. J. Psychiat. 109: 56–65, 1963.

Gershon S. : Lithium in Mania, Clin. Pharmacol. Ther. 11: 168–187, 1970.

Prien R. F. Caffey E. M. Klett C. J. : Prophylactic Efficacy of Lithium Carbonate in Manic-Depressive Illness, Arch. Gen. Psychiat. 28: 377–341, 1973.

Prien R. F. Caffey E. M. Klett C. J. : Comparison of Lithium Carbonate and Chlorpromazine in the Treatment of Mania, Arch. Gen. Psychiat. 26: 146–153, 1972.

Zall H. : Lithium Carbonate; a Clinical Study, Amer. J. Psychiat. 125: 549–555, 1968.

Baastrup P. C. Schou M. : Lithium as a Prophylactic Agent. Its Effect in Recurrent Depressions and Manic Depressive Psychosis, Arch. Gen. Psychiat. 16: 162–172, 1967.

Prien R. F. Klett C. J. Caffey E. M. : Lithium Carbonate and Imipramine in the Prevention of Affective Episodes, Arch. Gen. Psychiat. 29: 420–425, 1973.

Salkind M. R. : The Use of Sustained Release Lithium Carbonate in General Practice, J. Roy. Coll. Gen. Practit. 20: 13–21, 1970.

Mattson B. : Huntington's Chorea and Lithium Therapy, Lancet 1: 718–719, 1973.

Manyam N. V. B. Bravo-Fernandez E. : Lithium Carbonate in Huntington's Chorea, Lancet 1: 1010, 1973.

Dalén P. : Lithium in Tardive Dyskinesia and Huntington's Chorea, Lancet 1: 1078, 1973.

Mattson B. Persson S. : Huntington's Chorea, Lithium and G.A.B.A., Lancet 1: 684, 1973.

Dalén P. Steg G. : Lithium and Levodopa in Parkinsonism, Lancet 1: 936–937, 1973.

Aminoff M. J. Marshall J. : Treatment of Huntington's Chorea with Lithium Carbonate, a Double Blind Trial, Lancet 1: 107–109, 1974.

Platman S. R. : Absorption and Excretion of Lithium in Manic-Depressive Disease, Dis. Nerv. Syst. 29: 733–738, 1968.

Schou M. : Lithium: Elimination Rate, Dosage, Control, Goitre, Mode of Action, Acta. Psychiat. Scand. 207: 49–54, 1969.

Schou M. Shaw D. M. : Lithium in Recurrent Manic-Depressive Disorders, Practitioner 210: 105–111, 1973.

Platman S. R. Feive R. R. : Biochemical Aspects of Lithium in the Affective Disorders, Arch. Gen. Psychiat. 19: 659–663, 1968.

Corcoran A. C. : Lithium Poisoning from the Use as Salt Substitutes, J. Amer. Med. Assoc. 139: 685–688, 1949.

Soloff L. A. Zatuchi J. : Salt Depletion Syndrome in Patients on Lithium Chloride Salt Substitutes, J. Amer. Med. Assoc. 139: 1136, 1949.

Talbott J. H. : Use of Lithium Salts as a Substitute for Sodium Chloride, Arch. Intern. Med. 85: 1–10, 1950.

Singer I. Rotenberg D. : Mechanisms of Lithium Action, New Engl. J. Med. 289: 254–260, 1973.

Shaw D. M. : Mineral Metabolism, Mania and Melancholia, Brit. Med, J. 2: 262–267, 1966.

Corrodi H. : The Effect of Lithium on Cerebral Monoamine Hormones, Psychopharmacologica 11: 340–353, 1967.

Ashcroft G. W. : Modified Amine Hypothesis for the Aetiology of Affective Illness, Lancet 2: 573–577, 1972.

Coppen A. : Effects of Lithium Carbonate on Electrolyte Distribution in Man, Lancet 1: 682–683, 1965.

Hullin R. P. : Serum Lithium Levels in Patients Maintained on 400 mg Sustained Release Lithium Carbonate, Personal Communication, Delandale Laboratories, Canterbury, England, 1970.

Allgén L-G. : Laboratory Experience with Lithium Toxicity in Man, Acta. Psychiat. Scand. 207: 98–104, 1969.

Pybus J. Bowers G. N. : Measurement of Serum Lithium by Atomic Absorption Spectroscopy, Clin. Chem. 16: 139–143, 1970.

Amdisen A. : Serum Lithium Determinations for Clinical Use, Scand. J. Clin. Invest. 20: 104–108, 1967.

Greene R. J. Higgins D. Norton D. A. : The ‘West Cornwall’ System in Psychiatric Hospitals, Pharm. J. 210: 353–355, 1973.

Ellis D. D. Greene R. J. : Recording Lithium Therapy, Lancet 1: 719, 1973.

Borgsdorf L. R. Mosser R. S. : The Problem Oriented Medical Record, Amer. J. Hosp. Pharm. 30: 904–907, 1973.

Prescott L. F. : Plasma Concentrations in the Control of Drug Therapy, Preserver's J. 12: 101–108, 1973.

Koch-Weser J. : Drug Therapy; Serum Drug Concentrations as Therapeutic Guides, New Engt. J. Med. 287: 227–231, 1972.

Vesell E. S. Passanti G. T. : Utility of Clinical Chemical Determinations of Drug Concentrations in Biological Fluids, Clin. Chem. 17: 851–866, 1971.

Editorial: Aspects of Availability, Lancet 1: 245, 1973.

Giusti D. L. : Clinical Use of Antimicrobial Agents in Patients with Renal and Hepatic Insufficiency, Drug Intell. Clin. Pharm. 7: 540–553, 1973.

Curry S. H. : Plasma Levels of Psychotropic Drugs, and Their Possible Significance in Therapeutics, J. Hosp. Pharm. (Britain) 29: 308–316, 1971.

Richens A. Houghton G. W. : Phenytoin Intoxication Caused by Sulthiame, Lancet 2: 1442–1443, 1973.

Biological Availability, A Statement by the Dept. of Pharmaceutical Sciences, Pharmaceutical Society of Great Britain, Drug Intell. Clin. Pharm. 7: 116–119, 1973.

Wagner J. G. : Biologic Availability, Determinant Factor of Therapeutic Activity, Drug Intell. Clin. Pharm. 7: 168–176, 1973.

Blackwell B. : Drug Therapy; Patient Compliance, N. Engl. J. Med. 289: 249–252, 1973.

Horan V. : Patient Performance in the Self-Administration of Dispensed Medicines, J. Hosp. Pharm. (Britain) 31: 135–140, 1973.

Coppen A. : Slow Release Lithium Carbonate, J. Clin. Pharmacol. 9: 160–162, 1969.

Kirk L. : Propranolol Treatment of Lithium-Induced Tremor, Lancet 2: 1086–1087, 1973.

Villeneuve A. : Effect of Lithium on Thyroid in Man, Lancet 2: 502, 1973.

Segal R. L. : Endocrine Exophthalmos During Lithium Therapy, New Engl. J. Med. 289: 136–140, 1973.

Kirkegaard C. : Lithium and the Thyroid, Lancet 2: 1210, 1973.

Temple R. : The Use of Lithium in the Treatment of Thyrotoxicosis, J. Clin. Invest. 51: 2746–2756, 1972.

Meyler L. Herxheimer A. (editors): Side Effects of Drugs, Vol VII, Excerpta Medica, Amsterdam, p. 31–33, 1972.

von Hartitzsch B. : Permanent Neurological Sequelae Despite Haemodialysis for Lithium Intoxication, Brit. Med. J. 4: 757–759, 1972.

Platman S. R. Fieve R. R. : Lithium Retention and Excretion, Arch. Gen. Psychiat. 20: 285–289, 1969.

Bleiweiss H. : Salt Supplements With Lithium, Lancet 1: 416, 1970.

Thomson K. Schou M. : Renal Excretion of Lithium in Man, Amer. J. Physiol. 215: 823–827, 1968.

Öbek A. : Mannitol Infusions and Lithium Excretion, Brit. Med. J. 4: 550, 1972.

Amdisen A. Skjoldborg H. : Haemodialysis for Lithium Poisoning, Lancet 2: 213, 1969.

Juul-Jensen B. Schou M. : Permanent Brain Damage after Lithium Intoxication, Brit. Med. J. 4: 673, 1973.

Schou M. : Report from the Register of Lithium Babies, Brit. Med. J. 2: 135–136, 1973.

Schou M. : Hazards to Women Given Lithium During Pregnancy and Delivery, Brit. Med. J. 2: 137–138, 1973.

Stothers J. K. : Lithium Toxicity in the Newborn, Brit. Med. J. 3: 233–234, 1973.

Schou M. Amdisen A. : Lithium Ingestion by Children Breast-Fed by Women on Lithium Treatment, Brit. Med. J. 2: 138, 1973.

Ploeger E. J. : The Effects of Lithium on Excitable Cell Membranes, Europ. J. Pharmacol., 25: 316–321, 1974.